
Sign up to save your podcasts
Or


Koen De Witte, managing director of reMYND NV, headquartered in Leuven, Belgium, shares his thoughts with BioBoss host John Simboli about leadership and how reMYND is advancing treatments for Alzheimer’s, diabetes and other diseases caused by cellular dysfunction.
By John Simboli5
77 ratings
Koen De Witte, managing director of reMYND NV, headquartered in Leuven, Belgium, shares his thoughts with BioBoss host John Simboli about leadership and how reMYND is advancing treatments for Alzheimer’s, diabetes and other diseases caused by cellular dysfunction.

533 Listeners

3,071 Listeners

1,092 Listeners

942 Listeners

795 Listeners

125 Listeners

322 Listeners

96 Listeners

9,946 Listeners

34 Listeners

517 Listeners

146 Listeners

349 Listeners

181 Listeners

468 Listeners